The company said its Board of Directors declared a dividend of $0.432 per share on October 10, 2024 for Q4 2024.

8-KRegulation FD DisclosureFiled Oct 10, 2024Period of report Oct 10, 2024Summary published (UTC) Oct 28, 2026

Key points

AI summary

The company said its Board of Directors declared a dividend of $0.432 per share on October 10, 2024 for Q4 2024.
The company said it will pay the dividend on December 3, 2024 to shareholders of record as of the close of business on October 31, 2024.
The company said the filing is made under Item 7.01, Regulation FD Disclosure, and that the information, including Exhibit 99.1, is not deemed filed under the Securities Exchange Act of 1934. It said the attached 99.1 is a press release dated October 10, 2024.
Zoetis described itself in its press release as the world's leading animal health company, and said its 2023 revenue was $8.5 billion with approximately 14,100 employees.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Zoetis Declares Q4 2024 Dividend

The company said its Board of Directors declared a dividend of $0.432 per share on October 10, 2024 for Q4 2024.

Source · Based on the filing body and exhibits

Dividend Payment Date and Record Date

The company said it will pay the dividend on December 3, 2024 to shareholders of record as of the close of business on October 31, 2024.

Source · Based on the filing body and exhibits

Item 7.01 Filing Nature and Attached Press Release

The company said the filing is made under Item 7.01, Regulation FD Disclosure, and that the information, including Exhibit 99.1, is not deemed filed under the Securities Exchange Act of 1934. It said the attached 99.1 is a press release dated October 10, 2024.

Source · Based on the filing body and exhibits

Company Overview and 2023 Revenue

Zoetis described itself in its press release as the world's leading animal health company, and said its 2023 revenue was $8.5 billion with approximately 14,100 employees.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.